Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer
M. Stares, T. E. Ding, C. Stratton, F. Thomson, M. Baxter, H. Cagney, K. Cumming, A. Swan, F. Ross, C. Barrie, K. Maclennan, S. Campbell, T. Evans, A. Tufail, S. Harrow, H. Lord, B. Laird, M. MacKean, I. Phillips (Lead / Corresponding author)
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer'. Together they form a unique fingerprint.